National Institute of Allergy & Infectious Diseases: Clinical Trial to Test Immune Modulation Strategy for Hospitalized COVID-19 Patients Begins
September 23, 2023
September 23, 2023
WASHINGTON, Sept. 23 (TNSres) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
* * *
Part of NIH's STRIVE Consortium, the Therapeutic May Prevent Overactive Immune Systems from Causing Severe Symptoms
* * *
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild il . . .
* * *
Part of NIH's STRIVE Consortium, the Therapeutic May Prevent Overactive Immune Systems from Causing Severe Symptoms
* * *
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild il . . .